Clincosm LogoSign in Get a demo

recurrent renal cell carcinoma

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma Trial in Philadelphia (drug, procedure, other)

Recruiting
  • Recurrent Renal Cell Carcinoma
  • Renal Cell Carcinoma
  • Sulfur Hexafluoride Lipid Microspheres
  • +4 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 29, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +6 more
Oct 17, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Anti-OX40 Antibody PF-04518600
  • +3 more
  • Los Angeles, California
  • +9 more
Aug 5, 2022

Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Chicago (Stereotactic Body

Recruiting
  • Metastatic Renal Cell Cancer
  • +2 more
  • Stereotactic Body Radiation Therapy
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jun 3, 2022

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,

Completed
  • Metastatic Renal Cell Carcinoma
  • +4 more
  • HyperAcute®-Renal (HAR) Immunotherapy
  • Iowa City, Iowa
  • +2 more
Apr 4, 2022

Myeloid Derived Suppressor Cells Clinical Assay in Finding

Recruiting
  • Healthy Subject
  • +5 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 16, 2021

Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7 Trial in Bronx, New York

Completed
Has Results
  • Recurrent Renal Cell Carcinoma
  • +2 more
  • Bronx, New York
  • +3 more
Mar 17, 2021

Recurrent Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer Trial in Buffalo (other, procedure,

Terminated
Has Results
  • Recurrent Renal Cell Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 2, 2020

Metastatic Kidney Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States (Akt

Terminated
Has Results
  • Metastatic Kidney Carcinoma
  • +3 more
  • Akt Inhibitor MK2206
  • +2 more
  • Beverly Hills, California
  • +7 more
Sep 25, 2019

Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

Completed
  • Advanced Malignant Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jun 5, 2019

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Bevacizumab
  • +3 more
  • Scottsdale, Arizona
  • +523 more
Mar 5, 2019

Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (Erlotinib

Completed
Has Results
  • Recurrent Renal Cell Carcinoma
  • +4 more
  • Erlotinib Hydrochloride
  • +2 more
  • Tucson, Arizona
  • +213 more
Dec 12, 2018

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7 Trial in Peru, United States

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Bevacizumab
  • +4 more
  • Birmingham, Alabama
  • +558 more
Oct 15, 2018

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Australia, Taiwan, United

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • Anti-Endoglin Chimeric Monoclonal Antibody TRC105
  • +3 more
  • Duarte, California
  • +29 more
Jul 30, 2018

Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in San Antonio (Vorinostat)

Completed
Has Results
  • Recurrent Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer
  • San Antonio, Texas
  • +1 more
Oct 13, 2017

Adult Solid Tumor, Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma Trial in Madison (Computed Tomography,

Completed
  • Adult Solid Neoplasm
  • +4 more
  • Computed Tomography
  • +5 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Oct 9, 2017

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +13 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Palo Alto, California
  • +4 more
Sep 14, 2017

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Canada (Gamma-Secretase

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Gamma-Secretase Inhibitor RO4929097
  • Laboratory Biomarker Analysis
  • Vancouver, British Columbia, Canada
  • +3 more
Jan 19, 2017

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Houston (drug, biological,

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Sorafenib Tosylate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 28, 2016

Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Canada (drug, procedure, other)

Completed
Has Results
  • Recurrent Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer
  • Cediranib Maleate
  • +3 more
  • Edmonton, Alberta, Canada
  • +5 more
Jan 29, 2016